What is the difference between transparency requirements and safety requirements under the EU AI Act for GPAI?

Where Transparency Ends and Safety Begins for GPAI

For GPAI under the eu ai act, the distinction matters because the two requirements answer different governance questions. Transparency requirements are about disclosure: what the model is, what it can and cannot do, what it was trained on in broad terms, and where known limitations sit. Safety requirements are about control: how the provider reduces foreseeable harm through testing, mitigation, monitoring, and misuse resistance. The EU AI Act regulatory framework is the right starting point because it separates informational duties from risk-reduction duties rather than treating them as the same obligation.

Practitioners often blur the two and assume that a strong model card or technical disclosure package is evidence of safety. It is not. Transparency can help downstream deployers assess fit for purpose, but it does not by itself reduce harmful outputs, unsafe agentic behaviour, or misuse at scale. In practice, many teams encounter that confusion only after a release has already been assessed for documentation quality rather than for operational harm reduction.

How the Two Requirement Sets Work in Practice

In practice, transparency requirements ask the provider to make the system legible to others, while safety requirements ask the provider to demonstrate that the system is being managed as a risk-bearing product. That difference changes both the evidence and the workflow. Transparency artefacts typically include technical documentation, capability descriptions, training-data summaries at the level the Act requires, usage limitations, and instructions that help downstream actors understand intended and unintended use. Safety work typically includes structured evaluation, red-teaming, abuse testing, mitigation selection, incident handling, monitoring, and periodic review of whether the system remains acceptably controlled after release.

The practical separation is important because a model can be transparent and still be unsafe. A provider may accurately describe a model’s weaknesses, yet still fail to contain those weaknesses in real deployment. Equally, a provider can build useful mitigations without exposing every implementation detail publicly. The legal and operational question is not whether the organisation has “more information,” but whether the right information and the right controls are present for the right audience.

• Transparency supports informed use, procurement review, and downstream compliance decisions.
• Safety supports harm prevention, misuse resistance, and evidence that residual risk is being managed.
• Both depend on accurate documentation, but only safety requires the controls to be effective in operation.

For teams aligning governance, the safest approach is to treat transparency as an evidence layer and safety as a control layer. The transparency pack should describe the model honestly and consistently; the safety pack should show how the provider validates behaviour, limits exposure, and responds when risk changes after deployment. That distinction becomes especially important where model access is broad, outputs are reused in automated workflows, or the model can influence decisions that create real-world impact. Where the deployment is tightly bounded and low consequence, the transparency bar may still matter, but the safety programme can often remain proportionate to the actual use case rather than to generic AI alarm. This guidance breaks down when organisations try to reuse one document for both duties, because disclosure and control evidence answer different questions.

Common Variations, Grey Areas, and Deployment Boundaries

Tighter compliance often increases documentation and testing overhead, so organisations need to balance disclosure burden against the operational value of each requirement. That trade-off becomes visible when teams try to apply the same process to foundation-model release, internal model use, and downstream product integration without separating provider duties from deployer duties.

One common grey area is that transparency can look “safer” than it is. Detailed limitations may reduce misunderstanding, but they do not prevent misuse, prompt abuse, or unsafe chaining into other systems. Another is that safety controls are sometimes treated as purely technical, when governance choices matter too: who approves release, who owns residual risk, and who decides when monitoring evidence is strong enough to continue distribution. Guidance here is still developing in the market, so practitioners should label internal assumptions clearly rather than pretending there is universal consensus on one best operating model.

Another edge case appears when a GPAI model is embedded inside a product that looks ordinary to users. The provider may have strong transparency obligations for the model, while the integrator inherits practical safety responsibilities for the surrounding workflow, such as output filtering, human review, and misuse escalation. In those cases, a clean documentation set is necessary but not sufficient, because the downstream system can still fail even when the base model’s disclosures are accurate.

Practitioner Guidance

What to prioritise: Separate the evidence trail into two questions: what must users and deployers know about the model, and what must the organisation do to keep foreseeable harm under control. If a control only improves understanding, treat it as transparency; if it changes risk, treat it as safety.

What to verify: Check that disclosures are consistent with the actual behaviour seen in testing, and that safety evidence is tied to observed evaluation, mitigation, and monitoring activity rather than to policy language alone. A mismatch between the two is usually the clearest sign that governance is weaker than it appears.

Practitioner takeaway: The most important distinction is that transparency helps others judge the model, while safety proves the provider can manage its risk; treating one as a substitute for the other is a common governance failure.

Related resources from NHI Mgmt Group

• What is the difference between transparency controls and high-risk AI controls under the EU AI Act?
• What is the difference between prohibited AI practices and high-risk AI systems under the EU AI Act?
• Who is accountable when data sharing under the EU Data Act fails to meet fairness, transparency, or portability requirements?
• What is the difference between NIST AI RMF, ISO 42001, and the EU AI Act?